Emulate - About the company
Emulate is a series E company based in Boston (United States), founded in 2013 by and . It operates as a Developer of in vitro models for drug development. Emulate has raised $225M in funding from investors like OS Fund, and ND Capital. The company has 29 active competitors, including 14 funded and 1 that has exited. Its top competitors include companies like CN Bio, Nortis and AxoSim.
Company Details
Developer of in vitro models for drug development. The company has culture modules, organ-chips, and analytical software applications. The proprietary Organ-Chip models including the liver, intestine, kidney, and others contain tiny hollow channels lined with tens of thousands of living human cells and tissues are designed to predict human response.
- Website
- Social
- Email ID
- @emulatebio.com
- Phone Number
- +1
Key Metrics
Founded Year
2013
Location
Boston, United States
Stage
Series E
Total Funding
in 9 rounds
Latest Funding Round
Investors
Ranked
1st among 29 active competitors
Employee Count
as on Dec 31, 2023
Similar Companies
CN Bio &
Legal entities associated with Emulate
Emulate is associated with 2 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
---|---|---|---|---|
Sep 01, 2023 | - | 925 | 763 | |
Dec 31, 2012 | - | 469 | 260 |
Get your free copy of Emulate's company profile
Emulate's funding and investors
Emulate has raised a total funding of $225M over 9 rounds. Its first funding round was on Jul 28, 2014. Its latest funding round was a Series E round on Sep 07, 2021 for $82M. 2 investors participated in its latest round, which includes ATEL Capital Group, Founders Fund, CSC Upshot Ventures and Alumni Ventures.
Emulate has 24 institutional investors including OS Fund, and ND Capital. Hansjörg Wyss is only Angel Investor in Emulate.
Here is the list of recent funding rounds of Emulate:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
---|---|---|---|---|---|
Sep 07, 2021 | $82M | Series E | 3979410 | 2612498 | |
Mar 23, 2020 | $19.3M | Conventional Debt | 7246027 | 2336118 | - |
Aug 16, 2019 | $28M | Series C | 8175905 | 1127844 | - |
View details of Emulate's funding rounds and investors
Emulate's founders and board of directors
The founders of Emulate are and . is the CEO of Emulate. has founded 1 more company - Sight Diagnostics.
View details of Emulate's Founder profiles and Board Members
Emulate's employee count trend
Emulate has 103 employees as of Dec 23. The total employee count is 13.2% more than what it was in Dec 22. Here is Emulate's employee count trend over the years:Emulate's Competitors and alternates
Top competitors of Emulate include CN Bio, Nortis and AxoSim. Here is the list of Top 10 competitors of Emulate, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
---|---|---|---|---|---|
1st | 2013, Boston (United States), Series E | Developer of in vitro models for drug development | $225M | ATEL Capital Group, Founders FundÌý&²¹³¾±è;Ìý | 61/100 |
2nd | CN Bio 2009, Cambridge (United Kingdom), Series B | Develops organ-on-a-chip platforms for drug discovery | $44.8M | , Oxford University InnovationÌý&²¹³¾±è;Ìý | 61/100 |
3rd | Nortis 2007, Woodinville (United States), Acquired | Developer of platform for generating small segments of human tissues and organs in microfluidic chips | $10.7M | Emerging Technology Partners, Corewell Health VenturesÌý&²¹³¾±è;Ìý | 50/100 |
4th | AxoSim 2014, New Orleans (United States), Series A | Advancing nerve-on-a-chip technology to improve drug development. | $6.78M | 49/100 | |
5th | Developer of microfluidic devices for industrial applications | $8.89M | 48/100 | ||
6th | ![]() Mepsgen 2019, Seoul (South Korea), Series C | Developer of human organ model chips for pharmaceutical development | $29.3M | E&Investment, KB InvestmentÌý&²¹³¾±è;Ìý | 47/100 |
7th | ![]() Obatala Sciences 2017, New Orleans (United States), Series A | Provider of research enabling products and services to research centers | $3.53M | Springboard Enterprises, Reform VenturesÌý&²¹³¾±è;Ìý | 45/100 |
8th | Mimetas 2013, Leiden (Netherlands), Series B | Develops microfluidics-based organ-on-a-chip tissue models | $28.9M | EIC Fund, Merieux Equity PartnersÌý&²¹³¾±è;Ìý | 45/100 |
9th | Hesperos 2015, Orlando (United States), Funding Raised | Developer of organ-on-a-chip solutions for preclinical testing | - | 43/100 | |
10th | ![]() Cellbox Labs 2020, Riga (Latvia), Seed | Provider of organ-on-chip platform for drug discovery and development | $1.01M | 42/100 |
Looking for more details on Emulate's competitors? Click to see the top ones
Emulate's Investments and acquisitions
Emulate has made no investments or acquisitions yet.
Reports related to Emulate
Here is the latest report on Emulate's sector:
View
News related to Emulate
Media has covered Emulate for 1 event in last 1 year, It was about company updates.
•
Business Wire•Sep 29, 2024•Emulate
•
PR Newswire•Oct 12, 2023•Emulate
•
Business Wire•Jun 26, 2023•Emulate
•
Tullahoma News•Mar 02, 2023•Emulate
•
Business Wire•Sep 19, 2022•Emulate
•
Business Wire•May 09, 2022•Emulate
•
Business Wire•Mar 08, 2022•Emulate
•
•
Business Wire•Feb 03, 2022•Emulate
•
Frequently asked questions about Emulate
When was Emulate founded?
Emulate was founded in 2013.Where is Emulate located?
Emulate is located in Boston, United States.Is Emulate a funded company?
Emulate is a funded company, its first funding round was on Jul 28, 2014.When was the latest funding round of Emulate?
Emulate's latest funding round was on Sep 07, 2021.What is the annual revenue of Emulate?
Annual revenue of Emulate is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies
212K+ Investors
580K+ Funding Rounds
207K+ Acquisitions
2.9K+ Sectors
57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Pubcare - Fukuoka based, 2020 founded, Unfunded company
- Artesian Scrubbing Bubbles - Martinsville based, Unfunded company
- Three Point O Labs - Hyderabad based, 2022 founded, Unfunded company
- All Klaipeda Hotels - Klaipeda based, 2016 founded, Unfunded company
- Grandmas Jam House - 1995 founded, Unfunded company
- Supple Bodies - Salt Lake City based, 2004 founded, Unfunded company